Advion BioSciences Signs $9M Service Contract with Top-10 Pharma | GenomeWeb

NEW YORK, Dec. 16 (GenomeWeb News) - Advion BioSciences said today that it has signed a three-year mass spectrometry services contract worth $9 million with an undisclosed "top-10 pharmaceutical company."

Advion will provide scientists and instrumentation to support the pharmaceutical client's bioanalytical method development, method validation, and sample analysis programs, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.